Interactions between vasoconstrictors in isolated human cerebral arteries

Acta Neurochirurgica

Volumn 139, Issue 6, 1997, Pages 574-582

  Hempelmann, R G ^a,b   Pradel, R H E ^a   Barth, H L ^a   Mehdorn, H M ^a   Ziegler, A ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

5 Hydroxytryptamine; Endothelin 1; Human cerebral arteries; Thromboxane A2

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ENDOTHELIN 1; SEROTONIN; THROMBOXANE A2; VASOCONSTRICTOR AGENT;

ARTERY CONSTRICTION; ARTICLE; BRAIN ARTERY; BRAIN VASOSPASM; HUMAN; HUMAN TISSUE; PIA ARTERY; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE;

EID: 0030919625     PISSN: 00016268     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02751003     Document Type: Article

References (67)

1. Allen GS, Gold LHA, Chou SN, Frech LA (1974a) Cerebral arterial spasm: Part 3. In vivo intracisternal production of spasm by serotonin and blood and its reversal by phenoxybenzamine. J Neurosurg 40: 451-458
2. Allen GS, Henderson LM, Chou SN, Frech LA (1974b) Cerebral arterial spasm: Part 2. In vitro contractile activity of serotonin in human serum and CSF on the canine basilar artery, and its blockade by methysegide and phenoxybenzamine. J Neurosurg 40: 442-450
3. Auer LM, Leber K, Sayama I (1985) Effect of serotonin and its antagonist ketanserin on pial vessels. J Cereb Blood Flow Metab 5: 517-522
4. Bacic F, Uematsu S, McCarron RM, Spatz M (1992) Secretion of immunoreactive endothelin-1 by capillary and microvascular endothelium of human brain. Neurochem Res 17: 699-702
5. Brandt L, Andersson K-E, Edvinsson L. Ljunggren B (1981) Effects of extracellular calcium and of calcium antagonists on the contractile responses of isolated human pial and mesenteric arteries. J Cereb Blood Flow Metab 1: 339-347
6. Chan RC, Durity FA, Thompson GB, Nugent RA, Kendall M (1984) The role of the prostacyclin-thromboxane system in cerebral vasospasm following induced subarachnoid hemorrhage in the rabbit. J Neurosurg 61: 1120-1128
7. A receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrhage after intracisternal but not intravenous injection. Life Sci 52: 825-834
8. 2-receptor agonist, U46619. Br J Pharmacol 110: 360-368
9. Cocks TM, Malta E, King SJ, Woods RL, Angus JA (1991) Oxyhaemoglobin increases the production of endothelin-1 by endothelial cells in culture. Eur J Pharmacol 196: 177-182
10. Conde MV, Marco EJ, Fraile ML, Benito JM, Moreno MJ, Sanz ML, Lopez de Pablo A (1991) Different influence of the endothelium in the mechanical responses of human and cat isolated cerebral arteries to several agents. J Pharm Pharmacol 43: 255-261
11. Consigny PM (1990) Endothelin-1 increases arterial sensitivity to 5-hydroxytryptamine. Eur J Pharmacol 186: 239-245
12. Cook DA (1995) Mechanisms of cerebral vasospasm in subarachnoid haemorrhage. Pharmac Ther 66: 259-284
13. Dupont JR, van Wan CA, Kraintz L (1961) The clearance of major components of whole blood from cerebrospinal fluid following simulated subarachnoid hemorrhage. J Neuropath Exp Neurol 20: 450-455
14. Faraci FM (1992) Regulation of the cerebral circulation by endothelium. Pharmac Ther 56: 1-22
15. Findlay JM, Weir BKA, Kanamaru K, Espinosa F (1989) Arterial wall changes in cerebral vasospasm. Neurosurgery 25: 736-745
16. Findlay JM, Macdonald RL, Weir BK (1991) Current concepts of pathophysiology and management of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Cerebrovasc Brain Metab Rev 3: 336-361
17. Foley PL, Caner HH, Kassell NF, Lee KS (1994) Reversal of subarachnoid hemorrhage-induced vasoconstriction with an endothelin receptor antagonist. Neurosurgery 34: 108-112
18. Fujimori A, Yanagisawa M, Saito A, Goto K, Masaki T, Mima T, Takakura K, Shigeno T (1990) Endothelin in plasma and cerebrospinal fluid of patients with subarachnoid haemorrhage. Lancet 336: 633 (letter)
19. Gaetani P, Rodriguez y Baena R, Grignani G, Spanu G, Pacchiarini L, Paoletti P (1994) Endothelin and aneurysmal subarachnoid haemorrhage: a study of subarachnoid cisternal cerebrospinal fluid. J Neurol Neurosurg Psychiatry 57: 66-72
20. 1D binding sites. Br J Pharmacol 102: 227-233
21. Hatake K, Wakabayashi I, Kakishita E, Hishida S (1992) Impairment of endothelium-dependent relaxation in human basilar artery after subarachnoid hemorrhage. Stroke 23: 1111-1117
22. Hempelmann RG, Ziegler A (1993) Endothelium-dependent noradrenaline-induced relaxation of rat isolated cerebral arteries: pharmacological characterization of receptor subtypes involved. Br J Pharmacol 110: 1321-1328
23. Hempelmann RG, Barth HL, Mehdorn HM, Pradel RHE, Ziegler A (1995) Effects of potassium channel openers in isolated human cerebral arteries. Neurosurgery 37: 1146-1153
24. 2 receptor agonist). J Neurol 234: S 21 (abstract)
25. Hino A, Weir BKA, Macdonald RL, Thisted RA, Kim C-J, Johns LM (1995) Prospective, randomized, double-blind trial of BQ-123 and bosentan for prevention of vasospasm following subarachnoid hemorrhage in monkeys. J Neurosurg 83: 503-509
26. 2 on isolated human cerebral arteries. Acta Neurochir (Wien) 2: 177-185
27. Ito S, Sasaki T, Ide K, Ishikawa K, Nishikibe M, Yano M (1993) A novel endothelin ETA receptor antagonist, BQ-485, and its preventive effect on experimental cerebral vasospasm in dogs. Biochem Biophys Res Commun 195: 969-975
28. Jansen I, Blackburn T, Eriksen K, Edvinsson L (1991) 5-Hydroxytryptamine antagonistic effects of ICI 169,369, ICI 170,809 and methysergide in human temporal and cerebral arteries. Pharmacol Toxicol 68: 8-13
29. Kasuya H, Weir BKA, Nakane M, Pollock JS, Johns L, Marton LS, Stefansson K (1995) Nitric oxide synthase and guanylate cyclase levels in canine basilar artery after subarachnoid hemorrhage. J Neurosurg 82: 250-255
30. Kim P, Sundt TM, Vanhoutte PM (1988) Alterations in endothelium-dependent responsiveness of the canine basilar artery after subarachnoid hemorrhage. J Neurosurg 69: 239-246
31. Knuckey NW, Stokes BAR (1982) Medical management of patients following a ruptured cerebral aneurysm, with ε-aminocaproic acid, kanamycin, and reserpine. Surg Neurol 17: 181-185
32. Macdonald RL, Weir BKA (1991) A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 22: 971-982
33. Macdonald RL, Weir BKA, Runzer TD, Grace MGA, Findlay JM, Saito K, Cook DA, Mielke BW, Kanamaru K (1991) Etiology of cerebral vasospasm in primates. J Neurosurg 75: 415-424
34. Marin J, Lobato RD, Rico ML, Salaices M, Benitez J (1981) Effect of pentobarbital on the reactivity of isolated human cerebral arteries. J Neurosurg 54: 521-524
35. McPherson GA (1992) Assessing vascular reactivity of arteries in the small vessel myograph. Clin Exp Pharmacol Physiol 19: 815-825
36. Mulvany MJ, Halpern W (1977) Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 41: 19-26
37. A receptor antagonist. FR139317, ameliorates cerebral vasospasm in dogs. Life Sci 52: 1869-1874
38. Noseworthy TW, Weir B, Boisvert D, Espinosa F, Overton T. Marshal ML (1984) Effect of reserpine-kanamycin treatment on chronic vasospasm after platelet-enriched subarachnoid hemorrhage in primates. Neurosurgery 14: 193-197
39. Ohlstein EH, Storer BL (1992) Oxyhemoglobin stimulation of endothelin production in cultured endothelial cells. J Neurosurg 77: 274-278
40. Okwuasaba FK, Weir BKA, Cook DA, Krueger CA (1981) Effects of various intracranial fluids on smooth muscle. Neurosurgery 9: 402-406
41. Papadopoulos SM, Gilbert LL, Webb RC, D'Amato CJ (1990) Characterization of contractile responses to endothelin in human cerebral arteries: implications for cerebral vasospasm. Neurosurgery 26: 810-815
42. Parsons AA, Whalley ET (1989) Effects of prostanoids on human and rabbit basilar arteries precontracted in vitro. Cephalalgia 9: 165-171
43. 1-like receptors mediate 5-hydroxytryptamine-induced contraction of human isolated basilar artery. Br J Pharmacol 96: 434-449
44. Paul KS, Whalley ET, Forster C, Lye R, Dutton J (1982) Prostacyclin and cerebral vessel relaxation. J Neurosurg 57: 334-340
45. Poch G, Reiffenstein RJ, Köck P, Pancheva SN (1995) Uniform characterization of potentiation in simple and complex situations when agents bind to different molecular sites. Can J Physiol Pharmacol 73: 1574-1581
46. Pradel RHE, Ziegler A, Barth HL, Mehdorn HM, Hempelmann RG (1996) Interactions between different vasoconstrictors in human and rat isolated cerebral arteries. Naunyn Schmiedebergs Arch Pharmacol 353: R66 (abstract)
47. Sasaki T, Wakai S, Asano T, Takakura K, Sano K (1982) Prevention of cerebral vasospasm after SAH with a thromboxane synthetase inhibitor, OKY-1581. J Neurosurg 57: 74-82
48. Satoh S, Suzuki Y, Harada T, Ikegaki I, Asano T, Shibuya M, Sugita K, Saito A (1991) The role of platelets in the development of cerebral vasospasm. Brain Res Bull 27: 663-668
49. Schini VB, Hendrickson H, Heublein DM, Burnett FJC Jr, Vanhoutte PM (1989) Thrombin enhances the release of endothelin-1 from cultured porcine aortic endothelial cells. Eur J Pharmacol 165: 333-334
50. 2 in patients with subarachnoid hemorrhage. Surg Neurol 27: 243-252
51. Seifert V, Löffler B-M, Zimmermann M, Roux S, Stolke D (1995) Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 82: 55-62
52. Suzuki R, Masaoka H, Hirata Y, Marumo F, Isotani E, Hirakawa K (1992) The role of endothelin-1 in the origin of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 77: 96-100
53. 2. Neurosurgery 9: 679-685
54. Suzuki S, Sano K, Handa H, Asano T, Tamura A, Yonekawa Y, Ono H, Tachibana N, Hanaoka K (1989) Clinical study of OKY-046, a thromboxane synthetase inhibitor, in prevention of cerebral vasospasm and delayed cerebral ischemic symptoms after subarachnoid hemorrhage due to aneurysmal rupture: a randomized double-blind study. Neurol Res 11: 79-88
55. Szabò C, Emilsson K, Hardebo JE, Nystedt S, Owman C (1992) Uptake and release of serotonin in rat cerebrovascular nerves after subarachnoid hemorrhage. Stroke 23: 54-61
56. Toda N (1990) Mechanisms underlying responses to histamine of isolated monkey and human cerebral arteries. Am J Physiol 258: H311-H317
57. Tokiyoshi K, Ohnishi T, Nu Y (1991) Efficacy and toxicity of thromboxane synthetase inhibitor for cerebral vasospasm after subarachnoid hemorrhage. Surg Neurol 36: 112-118
58. 2α in human pial arteries. Acta Physiol Scand 121: 369-378
59. Van Nueten JM, Janssen PAJ, De Ridder W, Vanhoutte PM (1982) Interaction between 5-hydroxytryptamine and other vasoconstrictor substances in the isolated femoral artery of the rabbit: effect of ketanserin (R41468). Eur J Pharmacol 77: 281-287
60. Van Riper DA, Bevan JA (1991) Selective variation of agonist and neurally mediated vasoconstriction with rabbit middle cerebral artery branch order. J Pharmacol Exp Ther 257: 879-886
61. Voldby B, Engbaek I, Enevoldsen EM (1982) CSF serotonin concentrations and cerebral arterial spasm in patients with ruptured intracranial aneurysm. Stroke 13: 184-189
62. Wilkins RH (1986) Attempts at prevention or treatment of intracranial arterial spasm: an update. Neurosurgery 18: 808-825
63. Willette RN, Zhang H, Mitchell MP, Sauermelch CF, Ohlstein EH, Sulpizio AC (1994) Nonpeptide endothelin antagonist. Cerebrovascular characterization and effects on delayed cerebral vasospasm. Stroke 25: 2450-2455
64. Yang Z, Richard V, von Segesser L, Bauer E, Stulz P, Turina M, Lüscher TF (1990) Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries f- a new mechanism of vasospasm? Circulation 82: 188-195
65. 2 on human digital arteries. Clin Exp Pharmacol Physiol 13: 143-152
66. Zimmermann M, Seifert V, Löffler B-M, Stolke D, Stenzel W (1996) Prevention of cerebral vasospasm after experimental subarachnoid hemorrhage by RO 47-0203, a newly developed orally active endothelin receptor antagonist. Neurosurgery 38: 115-120
67. Zuccharello M, Soattin GB, Lewis AI, Breu V, Hallak H, Rapoport RM (1996) Prevention of subarachnoid hemorrhage-induced cerebral vasospasm by oral administration of endothelin receptor antagonists. J Neurosurg 84: 503-507